Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs62193003 | chr2:242535187 | G/A | 4.87E-11 | 177 | 25.87 | 24.7 | 10.3 | KM Plot |
PCPG | rs62193004 | chr2:242535385 | G/A | 4.67E-11 | 176 | 25.77 | 25 | 10.3 | KM Plot |
PCPG | rs62193006 | chr2:242536585 | G/A | 2.99E-5 | 176 | 25.87 | 27.27 | 20.28 | KM Plot |
PCPG | rs62193468 | chr2:242577916 | T/C | 9.01E-11 | 173 | 25.67 | 25 | 10.3 | KM Plot |
PCPG | rs62193473 | chr2:242579813 | C/T | 9.01E-11 | 173 | 25.67 | 25 | 10.3 | KM Plot |
PCPG | rs62226152 | chr21:34596750 | C/T | 0.000218 | 176 | 21.9 | 30.93 | 25.17 | KM Plot |
PCPG | rs62238886 | chr22:32141311 | G/A | 9.79E-6 | 178 | 25.87 | 12.57 | 1.3 | KM Plot |
PCPG | rs62254979 | chr3:80400835 | C/T | 5.33E-7 | 175 | 25.77 | 23.48 | 19.87 | KM Plot |
PCPG | rs62266920 | chr3:129048617 | G/A | 0.000101 | 174 | 25.28 | 30.33 | 19.87 | KM Plot |
PCPG | rs62266921 | chr3:129048654 | T/C | 0.000317 | 176 | 25.4 | 31.9 | 9.6 | KM Plot |
PCPG | rs62266925 | chr3:129052586 | G/A | 3.82E-5 | 176 | 25.53 | 25.27 | 9.6 | KM Plot |
PCPG | rs62266926 | chr3:129052933 | G/A | 0.000333 | 177 | 25.53 | 25.27 | 10.3 | KM Plot |
PCPG | rs62266928 | chr3:129056126 | T/C | 0.000333 | 176 | 25.67 | 25.27 | 10.3 | KM Plot |
PCPG | rs62266930 | chr3:129056788 | A/G | 0.000394 | 174 | 25.67 | 22.28 | 10.3 | KM Plot |
PCPG | rs62266932 | chr3:129057053 | T/C | 5.05E-5 | 172 | 25.4 | 25 | 9.6 | KM Plot |